XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis
Figure 6
Galbraith plots of XRCC3 C18067T polymorphism and skin cancer risk in dominant model TT/TC versus . CC.
The studies of Winsey et al. and Jacobsen et al. were spotted as outliers.